Asiri Surgical Hospital PLC (COSE:AMSL.N0000)
Sri Lanka flag Sri Lanka · Delayed Price · Currency is LKR
0.00
0.00 (0.00%)
Price not available due to exchange restrictions

Asiri Surgical Hospital Income Statement

Millions LKR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
7,6877,1826,6205,6355,8384,230
Revenue Growth (YoY)
10.32%8.49%17.48%-3.48%38.02%15.73%
Cost of Revenue
4,3474,1813,9503,4053,3782,661
Gross Profit
3,3403,0012,6702,2292,4601,568
Selling, General & Admin
2,4022,3762,2361,2741,042893.14
Operating Expenses
2,4022,3762,2361,2741,042893.14
Operating Income
937.97625.01433.92954.961,418675.12
Interest Expense
-292.17-338.39-615.62-947.73-247.04-245.53
Interest & Investment Income
607.59559.27767.971,218247.39246.34
Currency Exchange Gain (Loss)
3.93.98.225.17-8.010.94
Other Non Operating Income (Expenses)
29.2943.443.8230.853.3431.04
EBT Excluding Unusual Items
1,287893.19638.311,2611,464707.9
Gain (Loss) on Sale of Investments
---0.437.08-
Gain (Loss) on Sale of Assets
-0.01-0.01-0.02-0.44-0.670.86
Pretax Income
1,287893.18638.291,2611,470708.77
Income Tax Expense
657.25519.46515.28621.37223.6-150.9
Earnings From Continuing Operations
629.32373.73123.01640.031,246859.67
Minority Interest in Earnings
-113.98-108.06-91.46-84.91-61.62-37.51
Net Income
515.34265.6731.55555.121,185822.16
Net Income to Common
515.34265.6731.55555.121,185822.16
Net Income Growth
-742.03%-94.32%-53.14%44.10%89.83%
Shares Outstanding (Basic)
527528528528528528
Shares Outstanding (Diluted)
527528528528528528
EPS (Basic)
0.980.500.061.052.241.56
EPS (Diluted)
0.980.500.061.052.241.56
EPS Growth
-742.03%-94.32%-53.14%44.10%89.83%
Free Cash Flow
-290.2-435.0798.98248.36863.27431.56
Free Cash Flow Per Share
-0.55-0.820.190.471.630.82
Dividend Per Share
-0.300--2.1000.850
Dividend Growth
----147.06%-
Gross Margin
43.45%41.79%40.33%39.56%42.13%37.08%
Operating Margin
12.20%8.70%6.55%16.95%24.29%15.96%
Profit Margin
6.70%3.70%0.48%9.85%20.29%19.44%
Free Cash Flow Margin
-3.77%-6.06%1.49%4.41%14.79%10.20%
EBITDA
1,3371,015845.311,2981,736987.38
EBITDA Margin
17.40%14.13%12.77%23.03%29.74%23.34%
D&A For EBITDA
399.38389.79411.39342.75318.43312.26
EBIT
937.97625.01433.92954.961,418675.12
EBIT Margin
12.20%8.70%6.55%16.95%24.29%15.96%
Effective Tax Rate
51.09%58.16%80.73%49.26%15.21%-
Advertising Expenses
-21.8126.4226.3525.1414.24
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.